Preventive Vaccines Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Published : 30 Aug 2024
Report Type : Global

Share This On

Home > Reports > Diagnostics > Healthcare > Preventive Vaccines Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Chapter 1 Introduction

    1.1 Executive Summary

    1.2 Market Definition

    1.3 Scope of  the Study

Chapter 2 Research Methodology

    2.1 Secondary Research

    2.2 Primary Research

    2.3 Analytic Tools and Model

    2.4 Economic Indicator

            2.4.1 Base Year, Base Currency, Forecasting Period

    2.5 Expert Validation

    2.6 Study Timeline

Chapter 3 Market Analysis

    3.1 Industry Value Chain Analysis

    3.2 Porter's Five Analysis

            3.2.1 Bargaining Power of Buyers

            3.2.2 Bargaining Power of Suppliers

            3.2.3 Threats of Substitutes

            3.2.4 Threats of New Entrants

            3.2.5 Industry Rivalry

    3.3 PESTLE Analysis

            3.3.1 Political

            3.3.2 Economical

            3.3.3 Social

            3.3.4 Technological

            3.3.5 Legal

            3.3.6 Environmental

    3.4 SWOT Analysis

            3.4.1 Strengths

            3.4.2 Weakness

            3.4.3 Opportunities

            3.4.4 Threat

    3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

    4.1   Drivers

            4.1.1 Huge market demand

            4.1.2 Higher profitability and improved technology

            4.1.3 Government funded projects and Associations

    4.14 Increasing demand, higher onset of diseases

    4.2   Restraints

            4.2.1 High regulatory intervention and cost

            4.2.2 Increasing demand for cost-effective vaccines

    4.3   Opportunities

            4.3.1 New Target Populations-shift from established markets to lesser developed markets

    4.4   Challenges

            4.4.1 Difficult in development process

Chapter 5 Market Segmentation, By Type of Vaccine

         5.1 Recombinant Vector Vaccines

    5.2 DNA Vaccines

    5.3 Conjugate Vaccines

    5.4 Toxoid Vaccines

    5.5 Subunit Vaccines

    5.6 Inactivated Vaccines

    5.7 Live, Attenuated Vaccines                                      

Chapter 6 Market Segmentation, By Applications

          6.1 Pediatric Vaccine

            6.1.1 Combinations Vaccines

            6.1.1.1 Bivalent Vaccines

            6.1.1.2 Trivalent Vaccines

            6.1.1.3 Tetravalent Vaccines

            6.1.1.4 Pentavalent Vaccines

            6.1.2 HIB

            6.1.3 Hepatitis

            6.1.4 Poliovirus

            6.1.5 MMR

            6.1.6 Varicella Vaccines

            6.1.7 Pneumococcal Vaccines

            6.1.8 Others

    6.2 Adult Vaccine

            6.2.1 Zoster

            6.2.2 Hepatitis

            6.2.3 Cervical Cancer

            6.2.4  Influenza

            6.2.5 Others

Chapter 7 Market Segmentation, By Geography

    7.1 North America

            7.1.1 Introduction

            7.1.2 United States

            7.1.3 Canada

            7.1.4 Mexico

            7.1.5 Others

    7.2 Europe

            7.2.1 Introduction

            7.2.2 U.K

            7.2.3 Spain

            7.2.4 Italy

            7.2.5 France

            7.2.6 Russia

            7.2.7 Others

    7.3 Asia-Pacific

            7.3.1 Introduction

            7.3.2 China

            7.3.3 India

            7.3.4 Japan

            7.3.5 Australia

            7.3.6 Others

    7.4 South  America

            7.4.1 Introduction

            7.4.2 Brazil

            7.4.3 Argentina

            7.4.4 Others

    7.5 Middle East & Africa

            7.5.1 Introduction

            7.5.2 South Africa

            7.5.3 Others

Chapter 8 Competitive Landscape

    8.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

    8.2  Market Share Analysis

    8.3 Strategies Adopted By Top Companies

Chapter 9 Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

    9.1. Mitsubishi Tanabe

    9.2. AstraZeneca

    9.3. Astellas Pharma

    9.4. Takeda

    9.5. Emergent BioSolutions

    9.6. Pfizer

    9.7. Sanofi

    9.8. GlaxoSmithKline

    9.9. Merck & Co.

    9.10. Johnson & Johnson

    9.11. CSL

    9.12. Emergent Biosolutions

    9.13. Serum Institute

    9.14. MedImmune, LLC

    9.15. Bavarian Nordic

 

Chapter 10 Market Insights

    10.1 Insights of Industry Experts

    10.2 Analyst Opinion (Market Understanding)

    10.3 Investment Opportunities

Chapter 11 Appendix

    11.1 List of Tables

    11.2 List of Figures

Other Reports

Global Sesame Seeds Market – Size, Outlook, Trends and...

Starting from $2700

Global Meat Ingredients Market – Growth, Trends And...

Starting from $2700

Unmanned Aerial Vehicle Drones Market – Size, Outlook,...

Starting from $2700

Stay in the loop

Keep up-to-date with our weekly newsletter, Media Pulse.

Data-driven market insights & solutions

Follow Us On

We Accept

Our Office

30 N Gould St Ste N Sheridan,
WY 82801

© 2025 - Envision Intelligence | All Rights Reserved.
Designed by Webixion